IBRA HADAD & Fils is a Lebanon-based company founded in 1848 by Ibrahim Hadad, pioneering as the first chemical products trading entity in the Middle East. The company has expanded its reach across 20 countries, encompassing the healthcare markets in the Middle East, Gulf, and Africa. Specializing in the implementation, launching, promotion, and distribution of high-quality products for multinational companies, IBRA HADAD & Fils acts as their local agents. Their expertise spans a wide array of segments from fine chemicals to pharmaceutical products, supplements, diagnostic tools, medical devices, disposables, and lab equipment.
IBRA HADAD & Fils handles various aspects of business operations including business model strategies and implementations, contract negotiations and closures with local stakeholders, regulatory affairs, marketing, sales, customer service, logistics, distribution, promotion, and after-sales services and reporting. Their commitment to offering high-quality clinically proven solutions to the healthcare field sets them apart in the pharmaceutical industry.
Currently, there is no specific information available regarding the last investment or the investors involved with IBRA HADAD & Fils. However, their extensive experience, regional influence, and specialization in the healthcare industry position them as a compelling prospect for potential investors seeking opportunities in the Middle East and African markets.
There is no investment information
No recent news or press coverage available for IBRA HADAD & Fils.